Sign in

CIK 0001281895

  • Non-accelerated filer
  • Smaller reporting company

ROCKET PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 646-440-9100
Business address
350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
Former names
INOTEK PHARMACEUTICALS CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$395,614
in 3 filings

Net −$395,614. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Wilson Martin −$384K General Counsel sold 19% of stake
  2. Chaudhuri Sarbani −$11K See Remarks sold 2% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-05-17 Patel Kinnari See Remarks Sale −1,330 $21.38 $28K 213,993
2023-05-17 Shah Gaurav CEO Sale −4,122 $21.38 $88K 521,642
2023-05-17 Militello John See Remarks Sale −245 $21.38 $5K 6,116
2023-05-14 Shah Gaurav CEO Option exercise +7,979 525,764
2023-05-14 Shah Gaurav CEO Option exercise · Restricted Stock Units −7,979 55,856
2023-05-14 Militello John See Remarks Option exercise +725 6,361
2023-05-14 Militello John See Remarks Option exercise · Restricted Stock Units −725 5,078
2023-05-14 Patel Kinnari See Remarks Option exercise +3,989 215,323
2023-05-14 Patel Kinnari See Remarks Option exercise · Restricted Stock Units −3,989 27,982
2023-04-21 Militello John See Remarks Sale −2,342 $18.65 $44K 5,636
2023-04-18 Militello John See Remarks Option exercise +6,364 7,978
2023-04-18 Militello John See Remarks Option exercise · Restricted Stock Units +6,364 12,670
2023-04-04 White Mark Andrew Chief Medical Officer Grant or award +76,662 76,662
2023-04-04 White Mark Andrew Chief Medical Officer Grant or award · Stock Option (Right to Buy) +57,739 57,739
2023-02-17 Militello John See Remarks Sale −1,076 $19.06 $21K 1,782
2023-02-17 Schwartz Jonathan David See Remarks Sale −3,557 $19.06 $68K 94,546
2023-02-17 Militello John See Remarks Sale −1,244 $19.06 $24K 1,614
2023-02-17 Shah Gaurav CEO Sale −12,194 $19.06 $232K 536,885
2023-02-14 Shah Gaurav CEO Other acquisition +67,785 737,859
2023-02-14 Shah Gaurav CEO Other disposition · Restricted Stock Units −67,785 0

Page 16 of 19 · 374 trades